---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-015349"
form_type: "8-K"
ticker: "SYRA"
cik: "0001922335"
company_name: "Syra Health Corp"
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T05:16:38.331426+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Syra Health terminates CEO Deepika Vuppalanchi for cause; CFO appointed interim CEO

## Summary
- Board terminated CEO Deepika Vuppalanchi for cause on June 13, 2025.
- Priya Prasad, previously CFO and COO, appointed interim CEO effective June 16, 2025.
- Termination of employment agreement dated April 5, 2021 for cause.

## SEC filing metadata
- accession: 0001641172-25-015349
- form_type: 8-K
- ticker: SYRA
- cik: 0001922335
- company_name: Syra Health Corp
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1922335/000164117225015349/0001641172-25-015349-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1922335/000164117225015349/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-015349
- JSON: https://secwatch.observer/filing/0001641172-25-015349.json
- Plain text: https://secwatch.observer/filing/0001641172-25-015349.txt

## Key facts
- Executive change
  Priya Prasad was appointed as Interim Chief Executive Officer at Syra Health Corp.
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: the Board of Directors of the Company appointed Priya Prasad, the Company’s CFO and COO, as interim CEO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1922335/000164117225015349/0001641172-25-015349-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.